Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.44 USD | -1.23% | +7.41% | -14.21% |
05-08 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
05-08 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.21% | 2.66B | |
+3.35% | 108B | |
+11.00% | 104B | |
+1.28% | 22.33B | |
-12.05% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.94% | 17.64B | |
+4.33% | 14.05B | |
+34.45% | 12.51B |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Transcript : Denali Therapeutics Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 10